Skip N2 Metastasis in Pulmonary Adenocarcinoma: Good Prognosis Similar to N1 Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Skip N2 Metastasis in Pulmonary Adenocarcinoma: Good Prognosis Similar to N1 Disease

Published:2020-09 Issue:5 Volume:21 Page:e423-e434
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Wang Lin,Ye Guanzhi,Xue Liang,Zhan Cheng,Gu Jie,Xi Junjie,Lin Zongwu,Jiang Wei,Ge Di,Wang Qun

Funder

National Nature Science Foundation of China

Training Program for the Talents of Zhongshan Hospital

Fudan University

Youth Foundation of Zhongshan Hospital

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference32 articles.

1. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for lung cancer;Goldstraw;J Thorac Oncol,2016

2. Prognostic factors before and after recurrence of resected non–small cell lung cancer;Baba;Respir Investig,2012

3. Regional lymph node classification for lung cancer staging;Mountain;Chest,1997

4. Which is the better prognostic factor for resected non–small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?;Wei;J Thorac Oncol,2011

5. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non–small cell lung cancer;Saji;Chest,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of IASLC 9th Edition TNM Classification for Lung Cancer: Focus on N Descriptor;2024-08-11

2. Non–Small Cell Lung Cancer With N1 Involvement or Skip Metastases Presents the Same Survival Outcome: Results From a Multicentric Study;Clinical Lung Cancer;2023-11

3. Impact of skip mediastinal lymph node metastasis on outcomes after resection for primary lung cancer;Lung Cancer;2023-10

4. Do skip-N2 metastases significantly impact overall survival and disease-free interval in N2 non-small-cell lung cancer patients? A multicentre analysis;European Journal of Cardio-Thoracic Surgery;2023-06-27

5. Reconsidering N component of cancer staging for T1-2N0-2M0 small-cell lung cancer: a retrospective study based on multicenter cohort;Respiratory Research;2023-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3